Key Market Indicators
Canada's beta blocking medicine sales are expected to reach $200 million by 2026. In 2021, the country was ranked third in the world, with sales of $231 million. However, this figure represents a 2% year-on-year decrease from 2017. Italy overtook Canada in 2021 with sales of $231 million, while Australia was fourth with sales of an unknown amount.